BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 23623916)

  • 1. Significance of high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy.
    Kubo T; Kitaoka H; Yamanaka S; Hirota T; Baba Y; Hayashi K; Iiyama T; Kumagai N; Tanioka K; Yamasaki N; Matsumura Y; Furuno T; Sugiura T; Doi YL
    J Am Coll Cardiol; 2013 Oct; 62(14):1252-1259. PubMed ID: 23623916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and determinants of elevated high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy.
    Jenab Y; Pourjafari M; Darabi F; Boroumand MA; Zoroufian A; Jalali A
    J Cardiol; 2014 Feb; 63(2):140-4. PubMed ID: 24011925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined evaluation of coronary artery disease and high-sensitivity cardiac troponin T for prediction of adverse events in patients with hypertrophic cardiomyopathy.
    Liao H; Tan HC; Wang Z; Chen X; He Y; He S
    BMC Cardiovasc Disord; 2021 Jul; 21(1):325. PubMed ID: 34217206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated high-sensitivity troponin T levels are associated with adverse cardiac remodelling and myocardial fibrosis in hypertrophic cardiomyopathy.
    Hasler S; Manka R; Greutmann M; Gämperli O; Schmied C; Tanner FC; Biaggi P; Lüscher TF; Keller DI; Gruner C
    Swiss Med Wkly; 2016; 146():w14285. PubMed ID: 26999566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of highly sensitive cardiac troponin T in hypertrophic cardiomyopathy to left ventricular mass and cardiovascular risk.
    Cramer G; Bakker J; Gommans F; Brouwer M; Kurvers M; Fouraux M; Verheugt F; Kofflard M
    Am J Cardiol; 2014 Apr; 113(7):1240-5. PubMed ID: 24513467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of high sensitivity cardiac troponin T in patients with congenital heart disease.
    Abiko M; Inai K; Shimada E; Asagai S; Nakanishi T
    J Cardiol; 2018 Apr; 71(4):389-393. PubMed ID: 29108668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High T2-weighted signal intensity is associated with elevated troponin T in hypertrophic cardiomyopathy.
    Gommans DF; Cramer GE; Bakker J; Michels M; Dieker HJ; Timmermans J; Fouraux MA; Marcelis CL; Verheugt FW; Brouwer MA; Kofflard MJ
    Heart; 2017 Feb; 103(4):293-299. PubMed ID: 27506680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of High-Sensitivity Cardiac Troponin T to Predict Long-Term Outcome in Patients with Hypertrophic Cardiomyopathy.
    Gommans DHF; Cramer GE; Fouraux MA; Heijmans S; Michels M; Timmermans J; Verheugt FWA; de Boer RA; Kofflard MJM; Brouwer MA
    Am J Cardiol; 2021 Aug; 152():120-124. PubMed ID: 34130823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of infiltrative cardiomyopathy from hypertrophic cardiomyopathy using high-sensitivity cardiac troponin T: a case-control study.
    Kubo T; Baba Y; Hirota T; Tanioka K; Yamasaki N; Yamanaka S; Iiyama T; Kumagai N; Furuno T; Sugiura T; Kitaoka H
    BMC Cardiovasc Disord; 2015 Jun; 15():53. PubMed ID: 26077897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of high-sensitivity cardiac troponin T in patients with dilated cardiomyopathy.
    Baba Y; Kubo T; Yamanaka S; Hirota T; Tanioka K; Yamasaki N; Sugiura T; Kitaoka H
    Int Heart J; 2015 May; 56(3):309-13. PubMed ID: 25912901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of high-sensitivity cardiac troponin T and brain natriuretic peptide as biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Kawasaki T; Sakai C; Harimoto K; Yamano M; Miki S; Kamitani T
    Am J Cardiol; 2013 Sep; 112(6):867-72. PubMed ID: 23746480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of elevated high-sensitivity cardiac troponin T levels in a low risk outpatient population with cardiovascular disease.
    Biener M; Giannitsis E; Lamerz J; Mueller-Hennessen M; Vafaie M; Katus HA
    Eur Heart J Acute Cardiovasc Care; 2016 Oct; 5(6):409-418. PubMed ID: 26450785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The usefulness of sST2 and galectin-3 as novel biomarkers for better risk stratification in hypertrophic cardiomyopathy.
    Gawor M; Śpiewak M; Janas J; Kożuch K; Wróbel A; Mazurkiewicz Ł; Baranowski R; Marczak M; Grzybowski J
    Kardiol Pol; 2017; 75(10):997-1004. PubMed ID: 28612913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head-to-head comparison of high-sensitivity troponin T and sensitive-contemporary troponin I regarding heart failure risk stratification.
    de Antonio M; Lupón J; Galán A; Vila J; Zamora E; Urrutia A; Díez C; Coll R; Altimir S; Bayes-Genis A
    Clin Chim Acta; 2013 Nov; 426():18-24. PubMed ID: 23978483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of serum cardiac troponins T and I to predict cardiac molecular changes and cardiac damage in patients with hypertrophic cardiomyopathy.
    Okamoto R; Hirashiki A; Cheng XW; Yamada T; Shimazu S; Shinoda N; Okumura T; Takeshita K; Bando Y; Kondo T; Murohara T
    Int Heart J; 2013; 54(4):202-6. PubMed ID: 23924931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Sensitivity Cardiac Troponin T Elevation in Hypertrophic Cardiomyopathy Is Associated With Ventricular Arrhythmias.
    Burczak DR; Newman DB; Jaffe AS; Ackerman MJ; Ommen SR; Geske JB
    Mayo Clin Proc; 2023 Mar; 98(3):410-418. PubMed ID: 36868748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
    de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
    Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of high-sensitivity troponin T: a novel marker for cardiac remodeling in hypertrophic cardiomyopathy.
    Moreno V; Hernández-Romero D; Vilchez JA; García-Honrubia A; Cambronero F; Casas T; González J; Martínez P; Climent V; de la Morena G; Valdés M; Marín F
    J Card Fail; 2010 Dec; 16(12):950-6. PubMed ID: 21111984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy.
    O'Hanlon R; Grasso A; Roughton M; Moon JC; Clark S; Wage R; Webb J; Kulkarni M; Dawson D; Sulaibeekh L; Chandrasekaran B; Bucciarelli-Ducci C; Pasquale F; Cowie MR; McKenna WJ; Sheppard MN; Elliott PM; Pennell DJ; Prasad SK
    J Am Coll Cardiol; 2010 Sep; 56(11):867-74. PubMed ID: 20688032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of high sensitivity troponin T concentration in chronic stable patients with heart failure: Ischemic heart failure versus non-ischemic dilated cardiomyopathy.
    Bakal RB; Hatipoglu S; Kahveci G; Omaygenc MO; Unkun T; Akgun T; Sahin M; Elveran A; Ozveren O; Ozdemir N
    Cardiol J; 2014; 21(1):67-75. PubMed ID: 23799554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.